Effectiveness of Diabetes Mellitus Therapy
Abstract
Diabetes mellitus is called the silent killer because this disease can affect all organs of the body and cause various kinds of complaints. Evaluation of the rationality of oral antidiabetic drugs on the effectiveness of therapy for patients with type II diabetes mellitus, RSUD Dr. Moewardi Surakarta concluded that ADO (biguanide + sulfonylurea) combination therapy is a therapy that is often used in patients and is effective in reducing blood glucose levels within 3 months of treatment. The aim of this study is to know the effectiveness of type II diabetes mellitus treatment therapy, both single treatment (oral or insulin) and combination (oral + oral or oral + insulin) which can reduce blood glucose levels in patients in the outpatient installation of RSUD Dr. Moewardi Surakarta in 2023. This research is non-experimental with retrospective data collection looking at patient medical record data. The sample size was calculated using the Slovin formula so that 88 respondents were obtained. Profile of treatment therapy used in type II diabetes mellitus patients undergoing outpatient treatment at RSUD Dr. Moewardi Surakarta has the most combination therapy of long-acting insulin + rapid-acting insulin with a percentage of 36.4%, then the second most is premixed analog insulin monotherapy with a percentage of 10.2%. The results of the paired sample T-test can be stated that from the 1st to the 2nd month there was a significant decrease in blood sugar levels as well as in the 1st to 3rd month, this indicates that antidiabetic drugs, both oral and injectable, are effective for lower blood sugar levels.
References
Barbara G, W., Dipiro, J. T., Schwinghammer, T. L., & Dipiro, C. 2009. Pharmacotherapy Handbook Seventh Edition. Mc Graw Hill Medical Companies.
Charisma, A. M. (2017). Korelasi Kadar Rata-Rata Glukosa Darah Puasa dan 2 Jam Post Prandial Tiga Bulan Terakhir dengan Nilai HbA1C Pada Pasien Diabetes Melitus Prolanis BPJS Kabupaten Kediri Periode Mei-Agustus 2017. Jurnal Kesehatan Masyarakat Indonesia, 12(2), 1–11
Fatimah, R. N. 2015. Diabetes Melitus Tipe 2. J MAJORITY, 4(5), 93–101. https://juke.kedokteran.unila.ac.id/index.php/majority/article/view/615/619
Gamayanti, K. ayu V., Ratnasari, N. L. M. N., & Bhargah, A. 2018. Pola penggunaan insulin pada pasien diabetes mellitus tipe 2 di poli penyakit dalam RSU Negara Periode Juli - Agustus 2018. Intisari Sains Medis, 9(3), 68–73. https://doi.org/10.15562/ism.v9i3.306
Gunawan, S. G. 2016. Farmakologi dan Terapi (6th ed.). Departemen Farmakologi dan Terapeutik Fakultas Kedokteran Universitas Indonesia.
Hongdiyanto, A., Yamlean, P. V. Y., & Supriati, S. 2014. Evaluasi Kerasionalan Pengobatan Diabetes Melitus Tipe 2 Pada Pasien Rawat Inap Di Rsup Prof. Dr. R. D. Kandou Manado Tahun 2013. Pharmacon Jurnal Ilmiah Farmasi, 3(2), 77–87. https://ejournal.unsrat.ac.id/v3/index.php/pharmacon/article/view/4775/4297
International Diabetes Federation (IDF). 2021. International Diabetec Federation Atlas Tenth Edition. https://diabetesatlas.org/
Maisu, N. F. 2018. Analisis Rasionalitas Penggunaan Antidiabetes Pada Pasien Diabetes Melitus Tipe 2 di RSUD dr. Soediran Mangun Sumarso Wonogiri Tahun 2017. Universitas Setia Budi.
Perkumpulan Endokrinologi Indonesia. 2021. Pedoman Pengelolaan dan Pencegahan Diabetes Melitus Tipe 2 Dewasa di Indonesia. Jakarta : Pb. Perkeni
Rukminingsih, F., & Nova, V. C. (2021). Penggunaan Insulin Pada Pasien Diabetes Melitus Tipe 2 Peserta Jkn Di Instalasi Farmasi Rawat Jalan Rumah Sakit St. Elisabeth Semarang. Jurnal Ilmiah Ibnu Sina (JIIS): Ilmu Farmasi Dan Kesehatan, 6(1), 79–86. https://doi.org/10.36387/jiis.v6i1.611
